Pro strakan group plc – product pipeline review – 2012
Aarkstore.com announces, The Latest market research report is available inits vast collection:ProStrakan Group plc – Product Pipeline Review – 2012http://www.aarkstore.com/reports/ProStrakan-Group-plc-Product-Pipeline-Review-2012-217952.htmlRSS link of Global Markets Directhttp://www.aarkstore.com/feeds/Global-Markets-Direct.xmlSummaryGlobal Market Direct’s pharmaceuticals report, “ProStrakan Group plc - ProductPipeline Review - 2012” provides data on the ProStrakan Group plc’s research anddevelopment focus. The report includes information on current developmentalpipeline, complete with latest updates, and features on discontinued and dormantprojects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, ProStrakan Group plc’s corporate website, SEC filings,investor presentations and featured press releases, both from ProStrakan Group plcand industry-specific third party sources, put together by Global Markets Direct’steam.Scope- ProStrakan Group plc - Brief ProStrakan Group plc overview including businessdescription, key information and facts, and its locations and subsidiaries.- Review of current pipeline of ProStrakan Group plc human therapeutic division.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe.
Table of contents:List of Tables 5List of Figures 6ProStrakan Group plc Snapshot 7ProStrakan Group plc Overview 7Key Information 7Key Facts 7ProStrakan Group plc – Research and Development Overview 8Key Therapeutic Areas 8ProStrakan Group plc – Pipeline Review 10Pipeline Products by Stage of Development 10Pipeline Products – Monotherapy 11ProStrakan Group plc – Pipeline Products Glance 12ProStrakan Group plc – Late Stage Pipeline 12Phase III Products/Combination Treatment Modalities 12ProStrakan Group plc Clinical Stage Pipeline Products 13Phase II Products/Combination Treatment Modalities 13ProStrakan Group plc – Drug Profiles 14Abstral 14Product Description 14Mechanism of Action 14R&D Progress 14Sancuso 16Product Description 16Mechanism of Action 16R&D Progress 16SyB D-0701 17Product Description 17Mechanism of Action 17R&D Progress 17Testosterone-Glucoside 18Product Description 18Mechanism of Action 18R&D Progress 18
ProStrakan Group plc – Pipeline Analysis 19ProStrakan Group plc – Pipeline Products by Therapeutic Class 19ProStrakan Group plc – Pipeline Products By Target 21List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012http://www.aarkstore.com/search/viewresults.asp?search=Product PipelineReview&PubId=&pagenum=1Avir Green Hills Biotechnology AG – Product Pipeline Review – 2012BIOALVO S.A. – Product Pipeline Review – 2012Celator Pharmaceuticals, Inc. – Product Pipeline Review – 2012Cardio3 BioSciences SA – Product Pipeline Review – 2012Cornerstone Pharmaceuticals, Inc. – Product Pipeline Review – 2012Enzon Pharmaceuticals, Inc. – Product Pipeline Review – 2012iCo Therapeutics Inc. – Product Pipeline Review – 2012Neurocrine Biosciences, Inc. – Product Pipeline Review – 2012
Mersana Therapeutics, Inc. – Product Pipeline Review – 2012Nexgenix Pharmaceuticals, LLC – Product Pipeline Review – 2012Nuon Therapeutics, Inc. – Product Pipeline Review – 2012Osmotica Pharmaceutical Corp. – Product Pipeline Review – 2012SymBio Pharmaceuticals Limited – Product Pipeline Review – 2012ProStrakan Group plc – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1You can also request for sample page of above mention reports firstname.lastname@example.orgFor More details Plz do contact :Aarkstore EnterpriseLavanya